The kinetics of binding to p38 MAP kinase by analogues of BIRB 796

被引:93
作者
Regan, J
Pargellis, CA
Cirillo, PF
Gilmore, T
Hickey, ER
Peet, GW
Proto, A
Swinamer, A
Moss, N
机构
[1] Boehringer Ingelheim Pharmaceut, Dept Med Chem, Ridgefield, CT 06877 USA
[2] Boehringer Ingelheim Pharmaceut, Dept Immunol & Inflammat, Ridgefield, CT 06877 USA
关键词
D O I
10.1016/S0960-894X(03)00656-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
BIRB 796, a member of the N-pyrazole-N'-naphthly urea class of p38 MAPK inhibitors, binds to the kinase with both slow association and dissociation rates. Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a critical binding domain. We demonstrate that, independent of the loop movement, association rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring. As anticipated, the dissociation rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions. The value of structure-kinetic relationships (SKR) in drug design is discussed. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3101 / 3104
页数:4
相关论文
共 21 条
  • [1] The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
    Bresnihan, B
    [J]. BIODRUGS, 2001, 15 (02) : 87 - 97
  • [2] Cirillo Pier F., 2002, Current Topics in Medicinal Chemistry, V2, P1021, DOI 10.2174/1568026023393390
  • [3] INFLAMMATORY CYTOKINES - INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR AS EFFECTOR MOLECULES IN AUTOIMMUNE-DISEASES
    DINARELLO, CA
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (06) : 941 - 948
  • [4] Role of cytokines in rheumatoid arthritis
    Feldmann, M
    Brennan, FM
    Maini, RN
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 397 - 440
  • [5] p38 MAPK signalling cascades in inflammatory disease
    Herlaar, E
    Brown, Z
    [J]. MOLECULAR MEDICINE TODAY, 1999, 5 (10): : 439 - 447
  • [6] JACKSON PF, 2002, CURR TOP MED CHEM, V2, P1009
  • [7] Etanercept - A review of its use in rheumatoid arthritis
    Jarvis, B
    Faulds, D
    [J]. DRUGS, 1999, 57 (06) : 945 - 966
  • [8] A PROTEIN-KINASE INVOLVED IN THE REGULATION OF INFLAMMATORY CYTOKINE BIOSYNTHESIS
    LEE, JC
    LAYDON, JT
    MCDONNELL, PC
    GALLAGHER, TF
    KUMAR, S
    GREEN, D
    MCNULTY, D
    BLUMENTHAL, MJ
    HEYS, JR
    LANDVATTER, SW
    STRICKLER, JE
    MCLAUGHLIN, MM
    SIEMENS, IR
    FISHER, SM
    LIVI, GP
    WHITE, JR
    ADAMS, JL
    YOUNG, PR
    [J]. NATURE, 1994, 372 (6508) : 739 - 746
  • [9] Inhibition of p38 MAP kinase as a therapeutic strategy
    Lee, JC
    Kumar, S
    Griswold, DE
    Underwood, DC
    Votta, BJ
    Adams, JL
    [J]. IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 185 - 201
  • [10] Relationships between structure and interaction kinetics for HIV-1 protease inhibitors
    Markgren, PO
    Schaal, W
    Hämäläinen, M
    Karlén, A
    Hallberg, A
    Samuelsson, B
    Danielson, UH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) : 5430 - 5439